MeRes100TM is a bioresorbable vascular scaffold system that resorbs naturally in the artery within a period of 2-3 years thus leaving the vessel in its true form and nature.The complete resorption prevents chance of late clinical events like restenosis. Thus, also reducing likelihood of repeat revascularization versus metallic DES. MeRes100 is a 2nd generation bioresorbable technology with low strut thickness of 100microns leading to lower crossing profile for ease of delivery and early endothelialization. Couplets of tri-axial RO markers on both ends for enhanced visibility and large size matrix covers multitude of morphologies and lesions.
Stent material and thickness | Bioresorbable PLLA (Poly L-lactide) , 100 microns |
Stent architecture | Hybrid Design: Closed cells on ends and open cells in middle |
Material | |
Drug | Sirolimus |
Drug Dose | 1.25μg/mm2 |
Drug coating | Proprietary top coat |
Polymer | Bioresorbable PDLLA (Poly D,L-lactide) |
Delivery system | Rapid Exchange |
DIAMETER / LENGTH | 13 MM | 16 MM | 19 MM | 24 MM | 29 MM | 32 MM | 37 MM | 40 MM | |
---|---|---|---|---|---|---|---|---|---|
2.50 mm | MRS25013 | MRS25016 | MRS25019 | MRS25024 | MRS25029 | MRS25032 | MRS25037 | MRS25040 | |
2.75 mm | MRS27513 | MRS27516 | MRS27519 | MRS27524 | MRS27529 | MRS27532 | MRS27537 | MRS27540 | |
3.00 mm | MRS30013 | MRS30016 | MRS30019 | MRS30024 | MRS30029 | MRS30032 | MRS30037 | MRS30040 | |
3.25 mm | MRS32513 | MRS32516 | MRS32519 | MRS32524 | MRS32529 | MRS32532 | MRS32537 | MRS32540 | |
3.50 mm | MRS35013 | MRS35016 | MRS35019 | MRS35024 | MRS35029 | MRS35032 | MRS35037 | MRS35040 | |
4.00 mm | MRS40013 | MRS40016 | MRS40019 | MRS40024 | MRS40029 | MRS40032 | MRS40037 | MRS40040 | |
4.50 mm | MRS45013 | MRS45016 | MRS45019 | MRS45024 | MRS45029 | MRS45032 | MRS45037 | MRS45040 |